Phibro Animal Health PE Ratio 2012-2025 | PAHC
Current and historical p/e ratio for Phibro Animal Health (PAHC) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Phibro Animal Health PE ratio as of January 21, 2026 is 16.98.
| Phibro Animal Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-22 | 41.61 | 25.07 | |
| 2025-09-30 | 40.35 | $1.66 | 24.31 |
| 2025-06-30 | 25.39 | $1.18 | 21.51 |
| 2025-03-31 | 21.13 | $0.78 | 27.09 |
| 2024-12-31 | 20.67 | $0.48 | 43.06 |
| 2024-09-30 | 22.05 | $0.43 | 51.28 |
| 2024-06-30 | 16.32 | $0.06 | 272.04 |
| 2024-03-31 | 12.50 | $0.32 | 39.05 |
| 2023-12-31 | 11.09 | $0.36 | 30.82 |
| 2023-09-30 | 12.09 | $0.51 | 23.71 |
| 2023-06-30 | 12.86 | $0.81 | 15.87 |
| 2023-03-31 | 14.25 | $0.71 | 20.07 |
| 2022-12-31 | 12.38 | $0.90 | 13.75 |
| 2022-09-30 | 12.14 | $1.15 | 10.56 |
| 2022-06-30 | 17.34 | $1.21 | 14.33 |
| 2022-03-31 | 17.97 | $1.45 | 12.39 |
| 2021-12-31 | 18.29 | $1.31 | 13.96 |
| 2021-09-30 | 19.19 | $1.20 | 15.99 |
| 2021-06-30 | 25.60 | $1.34 | 19.10 |
| 2021-03-31 | 21.53 | $1.06 | 20.31 |
| 2020-12-31 | 17.05 | $1.09 | 15.64 |
| 2020-09-30 | 15.18 | $1.06 | 14.32 |
| 2020-06-30 | 22.79 | $0.82 | 27.79 |
| 2020-03-31 | 20.87 | $0.90 | 23.18 |
| 2019-12-31 | 21.33 | $0.94 | 22.69 |
| 2019-09-30 | 18.24 | $1.01 | 18.05 |
| 2019-06-30 | 27.00 | $1.35 | 20.00 |
| 2019-03-31 | 27.93 | $1.68 | 16.63 |
| 2018-12-31 | 27.11 | $1.80 | 15.06 |
| 2018-09-30 | 36.03 | $1.61 | 22.38 |
| 2018-06-30 | 38.60 | $1.60 | 24.12 |
| 2018-03-31 | 33.20 | $1.43 | 23.22 |
| 2017-12-31 | 27.95 | $1.53 | 18.27 |
| 2017-09-30 | 30.81 | $1.70 | 18.13 |
| 2017-06-30 | 30.73 | $1.62 | 18.97 |
| 2017-03-31 | 23.24 | $1.62 | 14.34 |
| 2016-12-31 | 24.15 | $1.49 | 16.21 |
| 2016-09-30 | 22.32 | $1.90 | 11.75 |
| 2016-06-30 | 15.26 | $2.06 | 7.41 |
| 2016-03-31 | 22.00 | $1.94 | 11.34 |
| 2015-12-31 | 24.43 | $1.97 | 12.40 |
| 2015-09-30 | 25.57 | $1.61 | 15.88 |
| 2015-06-30 | 31.39 | $1.66 | 18.91 |
| 2015-03-31 | 28.46 | $0.93 | 30.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.700B | $1.296B |
| Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.934B | 24.19 |
| EssilorLuxottica (ESLOY) | France | $146.214B | 0.00 |
| Stryker (SYK) | United States | $138.797B | 27.56 |
| Boston Scientific (BSX) | United States | $135.955B | 31.09 |
| Medtronic (MDT) | Ireland | $128.573B | 17.81 |
| Medline (MDLN) | United States | $56.884B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.666B | 0.00 |
| Agilent Technologies (A) | United States | $39.625B | 25.05 |
| ResMed (RMD) | United States | $37.840B | 26.19 |
| GE HealthCare Technologies (GEHC) | United States | $36.943B | 17.67 |
| Koninklijke Philips (PHG) | Netherlands | $28.127B | 18.37 |
| Terumo (TRUMY) | Japan | $20.195B | 22.73 |
| Insulet (PODD) | United States | $20.046B | 62.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.153B | 10.70 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.928B | 0.00 |
| Baxter (BAX) | United States | $10.132B | 8.18 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.404B | 30.22 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.406B | 13.42 |
| Envista Holdings (NVST) | United States | $4.056B | 23.27 |
| BillionToOne (BLLN) | United States | $3.850B | 0.00 |
| ICU Medical (ICUI) | United States | $3.830B | 24.32 |
| Haemonetics (HAE) | United States | $3.282B | 14.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.222B | 14.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.147B | 47.00 |
| Perrigo (PRGO) | Ireland | $2.052B | 5.14 |
| QuidelOrtho (QDEL) | United States | $1.999B | 12.85 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| AtriCure (ATRC) | United States | $1.952B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.608B | 70.46 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.431B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.425B | 20.63 |
| Kestra Medical Technologies (KMTS) | United States | $1.377B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.230B | 365.00 |
| Capricor Therapeutics (CAPR) | United States | $1.111B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.010B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.893B | 10.09 |
| Omeros (OMER) | United States | $0.856B | 0.00 |
| Valneva SE (VALN) | France | $0.854B | 0.00 |
| CeriBell (CBLL) | United States | $0.822B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 16.08 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cerus (CERS) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Cresco Labs (CRLBF) | United States | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Quanterix (QTRX) | United States | $0.329B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.285B | 22.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.201B | 17.73 |
| OraSure Technologies (OSUR) | United States | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Accendra Health (ACH) | United States | $0.166B | 1.66 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.84 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.105B | 4.58 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 26.15 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.19 |
| Bonk (BNKK) | United States | $0.025B | 0.00 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |